HEADER DNA/ANTIBIOTIC 17-FEB-01 1I3W TITLE ACTINOMYCIN D BINDING TO CGATCGATCG COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5'-D(*C*GP*AP*TP*CP*GP*AP*(BRU)P*CP*GP)-3'; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ACTINOMYCIN D; COMPND 7 CHAIN: E, F, G, H; COMPND 8 SYNONYM: DACTINOMYCIN SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 MOL_ID: 2; SOURCE 4 ORGANISM_SCIENTIFIC: STREPTOMYCES ANTIBIOTICUS; SOURCE 5 ORGANISM_TAXID: 1890 KEYWDS ACTINOMYCIN D, ACTINOMYCIN, ANTIBIOTIC, ANTI CANCER, ANTITUMOR, KEYWDS 2 MISMATCH, CHROMOPHORE, DEPSIPEPTIDE, DNA-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.ROBINSON,Y.-G.GAO,X.-L.YANG,R.SANISHVILI,A.JOACHIMIAK,A.H.-J.WANG REVDAT 9 13-NOV-24 1I3W 1 REMARK REVDAT 8 10-JUL-24 1I3W 1 COMPND FORMUL LINK REVDAT 7 15-NOV-23 1I3W 1 LINK ATOM REVDAT 6 24-JUL-19 1I3W 1 REMARK DBREF LINK REVDAT 5 27-JUL-11 1I3W 1 REMARK REVDAT 4 13-JUL-11 1I3W 1 VERSN REVDAT 3 24-FEB-09 1I3W 1 VERSN REVDAT 2 01-APR-03 1I3W 1 JRNL REVDAT 1 21-MAY-01 1I3W 0 JRNL AUTH H.ROBINSON,Y.G.GAO,X.YANG,R.SANISHVILI,A.JOACHIMIAK,A.H.WANG JRNL TITL CRYSTALLOGRAPHIC ANALYSIS OF A NOVEL COMPLEX OF ACTINOMYCIN JRNL TITL 2 D BOUND TO THE DNA DECAMER CGATCGATCG. JRNL REF BIOCHEMISTRY V. 40 5587 2001 JRNL REFN ISSN 0006-2960 JRNL PMID 11341823 JRNL DOI 10.1021/BI002859Z REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 3 CROSS-VALIDATION METHOD : A POSTERIORI REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM 5% REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.239 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.237 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 980 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 19747 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.231 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.230 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 839 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 16195 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 360 REMARK 3 NUCLEIC ACID ATOMS : 770 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 188 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 ANGLE DISTANCES (A) : 0.024 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.068 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.039 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.037 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.008 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.081 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: SHELX-97 SWAT REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : G. PARKINSON, J. VOJTECHOSKY, L. REMARK 3 CLOWNEY, A.T. BRUNGER, H.M. BERMAN REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SHELX-97 HOPE REMARK 4 REMARK 4 1I3W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-FEB-01. REMARK 100 THE DEPOSITION ID IS D_1000012871. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-FEB-99 REMARK 200 TEMPERATURE (KELVIN) : 110.0 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9530 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : CUSTOM-MADE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19747 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 9.800 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.53000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: GLYCINE BUFFER, BARIUM CHLORIDE, REMARK 280 SPERMINE, PEG400, PH 4.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 80.18400 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 23.50650 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 23.50650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 120.27600 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 23.50650 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 23.50650 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 40.09200 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 23.50650 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 23.50650 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 120.27600 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 23.50650 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 23.50650 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 40.09200 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 80.18400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ACTINOMYCIN D IS A BICYCLIC PEPTIDE, A MEMBER OF THE REMARK 400 ACTINOMYCIN FAMILY. REMARK 400 HERE, ACTINOMYCIN D IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 THE ACTINOMYCIN D IS POLYPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ACTINOMYCIN D REMARK 400 CHAIN: E, F, G, H REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: ACTINOMYCIN D CONSISTS OF TWO PENTAMER RINGS LINKED REMARK 400 BY THE CHROMOPHORE (PXZ) REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 DC A 1 REMARK 465 DC C 21 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 DG A 2 P OP1 OP2 REMARK 470 DG C 22 P OP1 OP2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 DG A 2 C8 - N9 - C1' ANGL. DEV. = -8.3 DEGREES REMARK 500 DC A 5 O5' - C5' - C4' ANGL. DEV. = -5.9 DEGREES REMARK 500 DC A 5 P - O5' - C5' ANGL. DEV. = 10.9 DEGREES REMARK 500 DC A 5 C6 - N1 - C2 ANGL. DEV. = 2.6 DEGREES REMARK 500 DA A 7 O4' - C1' - N9 ANGL. DEV. = 2.7 DEGREES REMARK 500 DG A 10 O5' - C5' - C4' ANGL. DEV. = -5.0 DEGREES REMARK 500 DC B 15 O4' - C1' - N1 ANGL. DEV. = 2.4 DEGREES REMARK 500 DG B 16 O4' - C1' - N9 ANGL. DEV. = 3.6 DEGREES REMARK 500 BRU B 18 C3' - O3' - P ANGL. DEV. = -7.9 DEGREES REMARK 500 DG B 20 N3 - C4 - N9 ANGL. DEV. = -5.2 DEGREES REMARK 500 DG C 26 N3 - C4 - C5 ANGL. DEV. = 3.1 DEGREES REMARK 500 DT D 34 O5' - C5' - C4' ANGL. DEV. = -5.5 DEGREES REMARK 500 DC D 35 N1 - C2 - O2 ANGL. DEV. = -3.8 DEGREES REMARK 500 DG D 36 O4' - C1' - N9 ANGL. DEV. = -4.7 DEGREES REMARK 500 DC D 39 O4' - C4' - C3' ANGL. DEV. = -2.6 DEGREES REMARK 500 DG D 40 O4' - C4' - C3' ANGL. DEV. = -3.2 DEGREES REMARK 500 DG D 40 O4' - C1' - N9 ANGL. DEV. = 4.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 DVA E 8 PRO E 9 30.64 REMARK 500 DVA G 2 PRO G 3 35.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 DA A 3 0.07 SIDE CHAIN REMARK 500 DG A 10 0.05 SIDE CHAIN REMARK 500 DC B 11 0.07 SIDE CHAIN REMARK 500 DA B 13 0.07 SIDE CHAIN REMARK 500 DT B 14 0.10 SIDE CHAIN REMARK 500 DG B 20 0.06 SIDE CHAIN REMARK 500 DG C 22 0.09 SIDE CHAIN REMARK 500 DA C 23 0.07 SIDE CHAIN REMARK 500 DG C 26 0.08 SIDE CHAIN REMARK 500 DG D 32 0.08 SIDE CHAIN REMARK 500 DT D 34 0.06 SIDE CHAIN REMARK 500 DG D 40 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF ACTINOMYCIN D REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF ACTINOMYCIN D REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN G OF ACTINOMYCIN D REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN H OF ACTINOMYCIN D REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A7Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN Z3 REMARK 900 RELATED ID: 209D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF N8-ACTINOMYCIN D COMPLEXED WITH D(GAAGCTTC)2 REMARK 900 RELATED ID: 1UNM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 7-AMINOACTINOMYCIN D COMPLEXED WITH NON- REMARK 900 COMPLEMENTARY DNA REMARK 900 RELATED ID: 1A7Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D REMARK 900 RELATED ID: 1FJA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (AAGCGCTT)2 REMARK 900 RELATED ID: 173D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 2D55 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1DSC RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1L1V RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTNIOMYCIN D COMPLEXED WITH MISMATCHED DNA REMARK 900 (GTCACCGAC) REMARK 900 RELATED ID: 316D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF F8-ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1DSD RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GATGCTTC)2 REMARK 900 RELATED ID: 1MNV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (ATGCTGCAT)2 REMARK 900 RELATED ID: 1UNJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 7-AMINO-ACTINOMYCIN D COMPLEXED WITH A NON- REMARK 900 COMPLEMENTARY DNA (TTAGT)2 REMARK 900 RELATED ID: 1OVF RELATED DB: PDB REMARK 900 SOLUTIOM STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (CCGTTTTGTGG) REMARK 900 2 REMARK 900 RELATED ID: 1QFI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN X2 DBREF 1I3W A 1 10 PDB 1I3W 1I3W 1 10 DBREF 1I3W B 11 20 PDB 1I3W 1I3W 11 20 DBREF 1I3W C 21 30 PDB 1I3W 1I3W 21 30 DBREF 1I3W D 31 40 PDB 1I3W 1I3W 31 40 DBREF 1I3W E 1 11 NOR NOR00228 NOR00228 1 11 DBREF 1I3W F 1 11 NOR NOR00228 NOR00228 1 11 DBREF 1I3W G 1 11 NOR NOR00228 NOR00228 1 11 DBREF 1I3W H 1 11 NOR NOR00228 NOR00228 1 11 SEQRES 1 A 10 DC DG DA DT DC DG DA BRU DC DG SEQRES 1 B 10 DC DG DA DT DC DG DA BRU DC DG SEQRES 1 C 10 DC DG DA DT DC DG DA BRU DC DG SEQRES 1 D 10 DC DG DA DT DC DG DA BRU DC DG SEQRES 1 E 11 THR DVA PRO SAR MVA PXZ THR DVA PRO SAR MVA SEQRES 1 F 11 THR DVA PRO SAR MVA PXZ THR DVA PRO SAR MVA SEQRES 1 G 11 THR DVA PRO SAR MVA PXZ THR DVA PRO SAR MVA SEQRES 1 H 11 THR DVA PRO SAR MVA PXZ THR DVA PRO SAR MVA MODRES 1I3W BRU A 8 U URACIL MODIFIED WITH BR MODRES 1I3W BRU B 18 U URACIL MODIFIED WITH BR MODRES 1I3W BRU C 28 U URACIL MODIFIED WITH BR MODRES 1I3W BRU D 38 U URACIL MODIFIED WITH BR HET BRU A 8 20 HET BRU B 18 20 HET BRU C 28 20 HET BRU D 38 20 HET DVA E 2 7 HET SAR E 4 5 HET MVA E 5 8 HET PXZ E 6 22 HET DVA E 8 7 HET SAR E 10 5 HET MVA E 11 8 HET DVA F 2 7 HET SAR F 4 5 HET MVA F 5 8 HET PXZ F 6 22 HET DVA F 8 7 HET SAR F 10 5 HET MVA F 11 8 HET DVA G 2 7 HET SAR G 4 5 HET MVA G 5 8 HET PXZ G 6 22 HET DVA G 8 7 HET SAR G 10 5 HET MVA G 11 8 HET DVA H 2 7 HET SAR H 4 5 HET MVA H 5 8 HET PXZ H 6 22 HET DVA H 8 7 HET SAR H 10 5 HET MVA H 11 8 HETNAM BRU 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE HETNAM DVA D-VALINE HETNAM SAR SARCOSINE HETNAM MVA N-METHYLVALINE HETNAM PXZ 2-AMINO-1,9-DICARBONYL-4,6-DIMETHYL-10-DEHYDRO- HETNAM 2 PXZ PHENOXAZIN-3-ONE HETSYN PXZ PHENOXAZINE FORMUL 1 BRU 4(C9 H12 BR N2 O8 P) FORMUL 5 DVA 8(C5 H11 N O2) FORMUL 5 SAR 8(C3 H7 N O2) FORMUL 5 MVA 8(C6 H13 N O2) FORMUL 5 PXZ 4(C16 H12 N2 O6) FORMUL 9 HOH *188(H2 O) LINK O3' DA A 7 P BRU A 8 1555 1555 1.60 LINK O3' BRU A 8 P DC A 9 1555 1555 1.61 LINK O3' DA B 17 P BRU B 18 1555 1555 1.60 LINK O3' BRU B 18 P DC B 19 1555 1555 1.61 LINK O3' DA C 27 P BRU C 28 1555 1555 1.59 LINK O3' BRU C 28 P DC C 29 1555 1555 1.58 LINK O3' DA D 37 P BRU D 38 1555 1555 1.61 LINK O3' BRU D 38 P DC D 39 1555 1555 1.61 LINK C THR E 1 N DVA E 2 1555 1555 1.33 LINK OG1 THR E 1 C MVA E 5 1555 1555 1.34 LINK N THR E 1 C0 PXZ E 6 1555 1555 1.35 LINK C DVA E 2 N PRO E 3 1555 1555 1.34 LINK C PRO E 3 N SAR E 4 1555 1555 1.33 LINK C SAR E 4 N MVA E 5 1555 1555 1.33 LINK C0' PXZ E 6 N THR E 7 1555 1555 1.34 LINK C THR E 7 N DVA E 8 1555 1555 1.32 LINK OG1 THR E 7 C MVA E 11 1555 1555 1.33 LINK C DVA E 8 N PRO E 9 1555 1555 1.33 LINK C PRO E 9 N SAR E 10 1555 1555 1.34 LINK C SAR E 10 N MVA E 11 1555 1555 1.33 LINK C THR F 1 N DVA F 2 1555 1555 1.33 LINK OG1 THR F 1 C MVA F 5 1555 1555 1.32 LINK N THR F 1 C0 PXZ F 6 1555 1555 1.35 LINK C DVA F 2 N PRO F 3 1555 1555 1.32 LINK C PRO F 3 N SAR F 4 1555 1555 1.34 LINK C SAR F 4 N MVA F 5 1555 1555 1.33 LINK C0' PXZ F 6 N THR F 7 1555 1555 1.34 LINK C THR F 7 N DVA F 8 1555 1555 1.33 LINK OG1 THR F 7 C MVA F 11 1555 1555 1.32 LINK C DVA F 8 N PRO F 9 1555 1555 1.33 LINK C PRO F 9 N SAR F 10 1555 1555 1.34 LINK C SAR F 10 N MVA F 11 1555 1555 1.33 LINK C THR G 1 N DVA G 2 1555 1555 1.33 LINK OG1 THR G 1 C MVA G 5 1555 1555 1.33 LINK N THR G 1 C0 PXZ G 6 1555 1555 1.34 LINK C DVA G 2 N PRO G 3 1555 1555 1.35 LINK C PRO G 3 N SAR G 4 1555 1555 1.34 LINK C SAR G 4 N MVA G 5 1555 1555 1.33 LINK C0' PXZ G 6 N THR G 7 1555 1555 1.34 LINK C THR G 7 N DVA G 8 1555 1555 1.33 LINK OG1 THR G 7 C MVA G 11 1555 1555 1.32 LINK C DVA G 8 N PRO G 9 1555 1555 1.33 LINK C PRO G 9 N SAR G 10 1555 1555 1.34 LINK C SAR G 10 N MVA G 11 1555 1555 1.34 LINK C THR H 1 N DVA H 2 1555 1555 1.33 LINK OG1 THR H 1 C MVA H 5 1555 1555 1.34 LINK N THR H 1 C0 PXZ H 6 1555 1555 1.36 LINK C DVA H 2 N PRO H 3 1555 1555 1.34 LINK C PRO H 3 N SAR H 4 1555 1555 1.33 LINK C SAR H 4 N MVA H 5 1555 1555 1.33 LINK C0' PXZ H 6 N THR H 7 1555 1555 1.35 LINK C THR H 7 N DVA H 8 1555 1555 1.32 LINK OG1 THR H 7 C MVA H 11 1555 1555 1.33 LINK C DVA H 8 N PRO H 9 1555 1555 1.33 LINK C PRO H 9 N SAR H 10 1555 1555 1.33 LINK C SAR H 10 N MVA H 11 1555 1555 1.33 CISPEP 1 DVA E 2 PRO E 3 0 23.54 CISPEP 2 PRO E 3 SAR E 4 0 -6.40 CISPEP 3 PRO E 9 SAR E 10 0 1.34 CISPEP 4 DVA F 2 PRO F 3 0 -1.17 CISPEP 5 PRO F 3 SAR F 4 0 8.43 CISPEP 6 DVA F 8 PRO F 9 0 22.23 CISPEP 7 PRO F 9 SAR F 10 0 -7.73 CISPEP 8 PRO G 3 SAR G 4 0 -7.83 CISPEP 9 DVA G 8 PRO G 9 0 8.84 CISPEP 10 PRO G 9 SAR G 10 0 7.51 CISPEP 11 DVA H 2 PRO H 3 0 14.07 CISPEP 12 PRO H 3 SAR H 4 0 -8.14 CISPEP 13 DVA H 8 PRO H 9 0 13.09 CISPEP 14 PRO H 9 SAR H 10 0 -6.56 SITE 1 AC1 12 DG A 2 DA A 3 DC A 5 DG A 6 SITE 2 AC1 12 DC B 11 DC B 19 DG B 20 DT C 24 SITE 3 AC1 12 HOH E2005 HOH E2006 HOH E2008 HOH E2009 SITE 1 AC2 15 DG A 2 DC A 9 DG A 10 DC B 11 SITE 2 AC2 15 DG B 12 DA B 13 DC B 15 DG B 16 SITE 3 AC2 15 DT D 34 HOH F2004 HOH F2006 HOH F2007 SITE 4 AC2 15 HOH F2008 HOH F2009 MVA H 11 SITE 1 AC3 10 DT A 4 DG C 22 DA C 23 DC C 25 SITE 2 AC3 10 DG C 26 DC D 31 DG D 40 HOH G2007 SITE 3 AC3 10 HOH G2008 HOH G2010 SITE 1 AC4 15 DT B 14 DG C 22 DG C 30 DC D 31 SITE 2 AC4 15 DG D 32 DA D 33 DC D 35 DG D 36 SITE 3 AC4 15 MVA F 11 HOH H2001 HOH H2003 HOH H2004 SITE 4 AC4 15 HOH H2005 HOH H2006 HOH H2007 CRYST1 47.013 47.013 160.368 90.00 90.00 90.00 P 43 21 2 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021271 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021271 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006236 0.00000